Bausch Health Companies Inc. BHC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.01B | 10.75B | 10.43B | 10.16B | 9.92B |
| Total Other Revenue | 108.00M | 103.00M | 102.00M | 110.00M | 113.00M |
| Total Revenue | 11.11B | 10.85B | 10.53B | 10.27B | 10.03B |
| Cost of Revenue | 3.04B | 3.06B | 3.05B | 3.01B | 2.94B |
| Gross Profit | 8.07B | 7.80B | 7.48B | 7.25B | 7.09B |
| SG&A Expenses | 3.48B | 3.44B | 3.43B | 3.43B | 3.36B |
| Depreciation & Amortization | 929.00M | 955.00M | 986.00M | 1.00B | 1.02B |
| Other Operating Expenses | -1.00M | -5.00M | -5.00M | -6.00M | -6.00M |
| Total Operating Expenses | 8.09B | 8.11B | 8.11B | 8.07B | 7.96B |
| Operating Income | 3.02B | 2.74B | 2.42B | 2.20B | 2.07B |
| Income Before Tax | -353.00M | -732.00M | -940.00M | 367.00M | 520.00M |
| Income Tax Expenses | 475.00M | 361.00M | 285.00M | 247.00M | 199.00M |
| Earnings from Continuing Operations | -828.00 | -1.09K | -1.23K | 120.00 | 321.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.00M | -5.00M | 17.00M | 37.00M | 41.00M |
| Net Income | -841.00M | -1.10B | -1.21B | 157.00M | 362.00M |
| EBIT | 3.02B | 2.74B | 2.42B | 2.20B | 2.07B |
| EBITDA | 4.17B | 3.91B | 3.62B | 3.41B | 3.30B |
| EPS Basic | -2.27 | -2.95 | -3.24 | 0.42 | 0.97 |
| Normalized Basic EPS | 2.37 | 1.90 | 1.28 | 1.09 | 0.98 |
| EPS Diluted | -2.29 | -2.96 | -3.24 | 0.42 | 0.97 |
| Normalized Diluted EPS | 2.35 | 1.89 | 1.27 | 1.08 | 0.97 |
| Average Basic Shares Outstanding | 1.50B | 1.49B | 1.49B | 1.49B | 1.48B |
| Average Diluted Shares Outstanding | 1.50B | 1.50B | 1.49B | 1.49B | 1.49B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |